Trial intelligence / Profile preview

Safety of ComBe Five Pentavalent Vaccine in Vietnamese Children

NCT02904213Completed

Start
Sep 2016
Primary completion
Dec 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Open-label, single-arm trial of Unifive in diphtheria, Tetanus, pertussis and 2 more. Primary endpoints: Immediate Adverse Events, Solicited Adverse Events and 2 more. Started Sep 2016; status: completed.

02

Drugs

Unifive
03

Conditions

diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)

Beyond the preview

Go deeper on NCT02904213.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02904213.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call